...
首页> 外文期刊>Oncology letters >Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression
【24h】

Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression

机译:Guggulsterone通过诱导caspase依赖性凋亡和下调survivin和Bcl-2表达来抑制人胆管癌Sk-ChA-1和Mz-ChA-1细胞的生长

获取原文
获取原文并翻译 | 示例
           

摘要

Guggulsterone has recently been reported to demonstrate anti-tumor effects in a variety of cancers. The present study aims to investigate the biological roles and underlying mechanism of the action of guggulsterone in cholangiocarcinoma. The immortalized human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell lines were treated with various concentrations of the trans isomer of guggulsterone, Z-guggulsterone. Cellular proliferation was determined using the XTT assay. The apoptotic status of cholangiocarcinoma cells was assessed by Hoechst 33258 staining, DNA fragmentation assay and flow cytometry. Specific caspase inhibitor was used to explore the role of caspase in guggulsterone-induced apoptosis. A colorimetric assay was performed to measure the alterations of the activities of caspase-3, -8 and -9. Western blot analysis was used to detect the protein expression of survivin, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein and cleaved poly (adenosine diphosphate-ribose) polymerase (PARP). As revealed by the present data, guggulsterone significantly inhibited the growth of the two human cholangiocarcinoma cell lines by inducing cellular apoptosis. In addition, guggulsterone-induced apoptosis of cholangiocarcinoma cells was demonstrated to be partially inhibited by the caspase inhibitors z-VAD-fmk, z-LEHD-fmk and z-IETD-fmk, accompanied by the activation of caspases-3, -8 and -9, accumulation of cleaved PARP and decreased expression of survivin and Bcl-2. In conclusion, the present study demonstrated that guggulsterone was able to suppress the proliferation of cholangiocarcinoma by inducing caspase-dependent apoptosis and downregulating survivin and Bcl-2.
机译:最近有报道称古古甾酮在多种癌症中均表现出抗肿瘤作用。本研究旨在探讨古古甾酮在胆管癌中的生物学作用及其潜在机制。永生化的人类胆管癌Sk-ChA-1和Mz-ChA-1细胞系用不同浓度的古古甾酮,Z-古古甾酮的反式异构体处理。使用XTT测定法测定细胞增殖。胆管癌细胞的凋亡状态通过Hoechst 33258染色,DNA片段测定和流式细胞仪进行评估。使用特定的胱天蛋白酶抑制剂来研究胱天蛋白酶在古古甾酮诱导的细胞凋亡中的作用。进行比色测定以测量caspase-3,-8和-9活性的变化。 Western印迹分析用于检测survivin,B细胞淋巴瘤2(Bcl-2),Bcl-2相关X蛋白和裂解的聚腺苷二磷酸核糖聚合酶(PARP)的蛋白表达。如本数据所揭示的,古古甾酮通过诱导细胞凋亡显着地抑制了两种人胆管癌细胞系的生长。此外,已证明古古甾酮诱导的胆管癌细胞凋亡被caspase抑制剂z-VAD-fmk,z-LEHD-fmk和z-IETD-fmk部分抑制,并伴有caspases-3,-8和cspases的激活。 -9,裂解的PARP的积累和survivin和Bcl-2的表达降低。综上所述,本研究表明古古甾酮能够通过诱导caspase依赖性凋亡和下调survivin和Bcl-2抑制胆管癌的增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号